# Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

> **NCT00429962** · PHASE3 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 40 (actual)

## Conditions studied

- Choroidal Neovascularization
- Age-Related Macular Degeneration

## Interventions

- **DRUG:** intravitreal ranibizumab
- **DRUG:** intravitreal ranibizumab & photodynamic therapy

## Key facts

- **NCT ID:** NCT00429962
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2009-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00429962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00429962, "Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00429962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*